Sugi Predict

Sugi Predict / Compounds / SCHEMBL13326832

SCHEMBL13326832

SCHEMBL13326832

CC(C)(C)OC(=O)NC1CN(Cc2ccccc2)CC1c1nccs1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ UBE2M P61081 1/20 0.50
▸ DCUN1D1 Q96GG9 1/20 0.50
▸ KMT2A Q03164 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NTRK1 P04629 1/20 0.45
▸ SCN8A Q9UQD0 5/20 0.41
▸ SCN1A P35498 4/20 0.41
▸ HRH1 P35367 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ BCL2 P10415 1/20 0.39
▸ PDE4B Q07343 1/20 0.38
▸ NPFFR1 Q9GZQ6 1/20 0.38
▸ NPFFR2 Q9Y5X5 1/20 0.38
▸ KDM1A O60341 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ DRD2 P14416 2/20 0.37
▸ DRD4 P21917 2/20 0.37
▸ DRD3 P35462 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13326833 0.83 PDE4B (0.56) KMT2AL3MBTL1NTRK1PDE4B
SCHEMBL463075 0.83 KMT2A (0.47) UBE2MDCUN1D1KMT2AL3MBTL1NTRK1
SCHEMBL463076 0.83 KMT2A (0.47) UBE2MDCUN1D1KMT2AL3MBTL1NTRK1
SCHEMBL15716485 0.82 KMT2A (0.52) KMT2AL3MBTL1NTRK1JAK1PDE4B
SCHEMBL13858621 0.82 KMT2A (0.52) KMT2AL3MBTL1NTRK1JAK1PDE4B
SCHEMBL16780873 0.82 KMT2A (0.52) KMT2AL3MBTL1NTRK1JAK1PDE4B
SCHEMBL13858620 0.82 KMT2A (0.52) KMT2AL3MBTL1NTRK1JAK1PDE4B
SCHEMBL461319 0.80 KMT2A (0.46) UBE2MDCUN1D1KMT2AL3MBTL1JAK1
SCHEMBL463216 0.80 KMT2A (0.46) UBE2MDCUN1D1KMT2AL3MBTL1JAK1
SCHEMBL28046375 0.80 KMT2A (0.45) KMT2AL3MBTL1NTRK1JAK1BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713965-B2 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials VETOQUINOL SA (FR) 2010-05-11 — — US disclosed
US-7713965-B2 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials VETOQUINOL SA (FR) 2010-05-11 — — US disclosed
WO-2009106967-A1 NOVEL 7-SUBSTITUTED DERIVATIVES OF 3-CARBOXY-OXADIAZINO-QUINOLONES, PREPARATION THEREOF AND USE THEREOF AS ANTI-BACTERIAL AGENTS VETOQUINOL SA (FR) 2009-09-03 — — WO disclosed
US-20090221565-A1 NOVEL 7-SUBSTITUTED 3-CARBOXY-OXADIAZINO-QUINOLONE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTI-BACTERIALS VETOQUINOL SA (FR) 2009-09-03 — — US disclosed
US-20090221565-A1 NOVEL 7-SUBSTITUTED 3-CARBOXY-OXADIAZINO-QUINOLONE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTI-BACTERIALS VETOQUINOL SA (FR) 2009-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221565-A1 NOVEL 7-SUBSTITUTED 3-CARBOXY-OXADIAZINO-QUINOLONE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTI-BACTERIALS CBR3, CBR1, TECR UBE2M 2737/4885DCUN1D1 3236/4885KMT2A 3263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.